| 摘要: |
| ［摘要］ plazomicin是一种由西索米星为起始原料，经化学合成而得的新型氨基糖苷类药物，对大多数多药耐药菌具有较高的活性。与其他氨基糖苷类药物相似，plazomicin通过与细菌核糖体30S亚基结合抑制细菌蛋白质的合成。对大多数氨基糖苷类修饰酶有效，但不能抑制16S rRNA甲基化酶。该文对plazomicin的化学结构、抗菌机制、耐药机制、体内外抗菌活性、药动学、药效学、临床应用以及药物配伍方面作一综述。 |
| 关键词: Plazomicin 抗菌活性 临床应用 复杂性尿路感染 |
| DOI：10.3969/j.issn.1674-3806.2020.12.23 |
| 分类号:R 978.1 |
| 基金项目:广西卫健委科研课题（编号：Z20180751，Z20190662） |
|
| Research progress in the clinical application of a novel aminoglycoside plazomicin |
|
WANG Ya-le, XIE Xiao-qian, ZHAO Ze-yue, et al.
|
|
Department of Pharmacy, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang 471000, China
|
| Abstract: |
| ［Abstract］ Plazomicin is a novel aminoglycoside that is chemically synthesized from sisomicin with enhanced activity against most multidrug-resistant pathogens. Similar to other aminoglycosides, plazomicin inhibits protein synthesis by binding to the bacterial 30S ribosomal subunit. Plazomicin is engineered to overcome the most common aminoglycoside-modifying enzymes, but is not active against 16S rRNA methyltransferase. In this paper, we review the chemical structure, antibacterial mechanism, mechanism of drug resistance, antibacterial activity in vitro and in vivo, pharmacokinetics, pharmacodynamics, clinical application and drug compatibility of plazomicin. |
| Key words: Plazomicin Antibacterial activity Clinical application Complicated urinary tract infection(cUTI) |
